Board of Scientific Counselors, National Center for Health Statistics, 50824 [E8-19947]

Download as PDF 50824 Federal Register / Vol. 73, No. 168 / Thursday, August 28, 2008 / Notices Pneumococcal Vaccine Mild Problems: During studies of the vaccine, some children became fussy or drowsy or lost their appetite. Rotavirus Vaccine Mild Problems: Children who get rotavirus vaccine are slightly more likely than other children to have mild, temporary diarrhea or vomiting. This happens within the first week after getting a dose of vaccine. No moderate or serious problems have been associated with the vaccine. Precautions If your child is sick on the date vaccinations are scheduled, your provider may want to put them off until she recovers. A child with a mild cold or a low fever can usually be vaccinated that day. But for a more serious illnesses, it may be better to wait. Some children should not get certain vaccines. Talk with your provider if your child had a serious reaction after a previous dose of a vaccine, or has any life-threatening allergies. (These reactions and allergies are rare.) If your child had any of these reactions to a previous dose of DTaP: —A brain or nervous system disease within 7 days —Non-stop crying for 3 or more hours —A seizure or collapse —A fever over 105°F Talk to your provider before getting DTaP Vaccine. If your child has: —A life-threatening allergy to the antibiotics neomycin, streptomycin, or polymyxin B. Talk to your provider before getting Polio Vaccine. If your child has: —A life-threatening allergy to yeast Talk to your provider before getting Hepatitis B Vaccine. If your child has: —A weakened immune system —Ongoing digestive problems —Recently gotten a blood transfusion or other blood product —Ever had intussusception (an uncommon type of intestinal obstruction) Talk to your provider before getting Rotavirus Vaccine. jlentini on PROD1PC65 with NOTICES What if my child has a moderate or severe reaction? What should I look for? Look for any unusual condition, such as a serious allergic reaction, high fever, weakness, or unusual behavior. Serious allergic reactions are extremely rare with any vaccine. If one VerDate Aug<31>2005 17:36 Aug 27, 2008 Jkt 214001 were to happen, it would most likely come within a few minutes to a few hours after the shot. Signs of a serious allergic reaction can include: DEPARTMENT OF HEALTH AND HUMAN SERVICES —difficulty breathing —weakness —hives —hoarseness or wheezing —dizziness —paleness —swelling of the throat —fast heart beat Board of Scientific Counselors, National Center for Health Statistics In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92–463), the Centers for Disease Control and Prevention (CDC), National Center for Health Statistics (NCHS) announces the following meeting of the aforementioned committee. What should I do? Call a doctor, or get the child to a doctor right away. Tell your doctor what happened, the date and time it happened, and when the shot was given. Ask your healthcare provider to report the reaction by filing a Vaccine Adverse Event Reporting System (VAERS) form. Or you can file this report through the VAERS Web site at https:// www.vaers.hhs.gov, or by calling 1–800– 822–7967. VAERS does not provide medical advice. The National Vaccine Injury Compensation Program A federal program exists to help pay for the care of anyone who has a serious reaction to a vaccine. For information about the National Vaccine Injury Compensation Program, call 1–800–338–2382 or visit their Web site at https://www.hrsa.gov/ vaccinecompensation. For More Information Ask your healthcare provider. They can give you the vaccine package insert or suggest other sources of information. Call your local or state health department. Contact the Centers for Disease Control and Prevention (CDC) at 1–800– 232–4636 (1–800–CDC–INFO) . Visit CDC Web sites at: https:// www.cdc.gov/vaccines and https:// www.cdc.gov/ncidod/diseases/hepatitis. Dated: August 20, 2008. James D. Seligman, Chief Information Officer, Centers for Disease Control and Prevention (CDC). [FR Doc. E8–19965 Filed 8–27–08; 8:45 am] BILLING CODE 4163–18–P PO 00000 Centers for Disease Control and Prevention Times and Dates: 11 a.m.–5:30 p.m., September 18, 2008. 8:30 a.m.–2 p.m., September 19, 2008. Place: NCHS Headquarters, 3311 Toledo Road, Hyattsville, Maryland 20782. Status: Open to the public, limited only by the space available. The meeting room accommodates approximately 100 people. Purpose: This committee is charged with providing advice and making recommendations to the Secretary, Department of Health and Human Services; the Director, CDC; and the Director, NCHS, regarding the scientific and technical program goals and objectives, strategies, and priorities of NCHS. Matters To Be Discussed: The agenda will include welcome remarks by the Director, NCHS; introduction of members and key NCHS staff; scientific presentations and discussions; the review of the National Health Interview Survey; presentation of the long term care program in the initial stage of review; and an open session for comments from the public. Requests to make oral presentations should be submitted in writing to the contact person listed below. All requests must contain the name, address, telephone number, and organizational affiliation of the presenter. Written comments should not exceed five single-spaced typed pages in length and must be received by September 12, 2008. The agenda items are subject to change as priorities dictate. Contact Person for More Information: Virginia S. Cain, Ph.D., Director of Extramural Research, NCHS/CDC, 3311 Toledo Road, Room 7211, Hyattsville, Maryland 20782, telephone (301) 458–4500, fax (301) 458–4020. The Director, Management Analysis and Services Office, has been delegated the authority to sign Federal Register notices pertaining to announcements of meetings and other committee management activities for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: August 22, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8–19947 Filed 8–27–08; 8:45 am] BILLING CODE 4163–18–P Frm 00069 Fmt 4703 Sfmt 4703 E:\FR\FM\28AUN1.SGM 28AUN1

Agencies

[Federal Register Volume 73, Number 168 (Thursday, August 28, 2008)]
[Notices]
[Page 50824]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: E8-19947]


-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention


Board of Scientific Counselors, National Center for Health 
Statistics

    In accordance with section 10(a)(2) of the Federal Advisory 
Committee Act (Pub. L. 92-463), the Centers for Disease Control and 
Prevention (CDC), National Center for Health Statistics (NCHS) 
announces the following meeting of the aforementioned committee.

    Times and Dates: 11 a.m.-5:30 p.m., September 18, 2008. 8:30 
a.m.-2 p.m., September 19, 2008.
    Place: NCHS Headquarters, 3311 Toledo Road, Hyattsville, 
Maryland 20782.
    Status: Open to the public, limited only by the space available. 
The meeting room accommodates approximately 100 people.
    Purpose: This committee is charged with providing advice and 
making recommendations to the Secretary, Department of Health and 
Human Services; the Director, CDC; and the Director, NCHS, regarding 
the scientific and technical program goals and objectives, 
strategies, and priorities of NCHS.
    Matters To Be Discussed: The agenda will include welcome remarks 
by the Director, NCHS; introduction of members and key NCHS staff; 
scientific presentations and discussions; the review of the National 
Health Interview Survey; presentation of the long term care program 
in the initial stage of review; and an open session for comments 
from the public.
    Requests to make oral presentations should be submitted in 
writing to the contact person listed below. All requests must 
contain the name, address, telephone number, and organizational 
affiliation of the presenter.
    Written comments should not exceed five single-spaced typed 
pages in length and must be received by September 12, 2008.
    The agenda items are subject to change as priorities dictate.
    Contact Person for More Information: Virginia S. Cain, Ph.D., 
Director of Extramural Research, NCHS/CDC, 3311 Toledo Road, Room 
7211, Hyattsville, Maryland 20782, telephone (301) 458-4500, fax 
(301) 458-4020.
    The Director, Management Analysis and Services Office, has been 
delegated the authority to sign Federal Register notices pertaining 
to announcements of meetings and other committee management 
activities for both CDC and the Agency for Toxic Substances and 
Disease Registry.

    Dated: August 22, 2008.
Elaine L. Baker,
Director, Management Analysis and Services Office, Centers for Disease 
Control and Prevention.
[FR Doc. E8-19947 Filed 8-27-08; 8:45 am]
BILLING CODE 4163-18-P
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.